慢性髓性白血病的爆发期呈现为早期T细胞前体急性淋巴细胞白血病
1Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, US.
American journal of clinical pathology
|September 5, 2024
概括
慢性髓性白血病爆发阶段 (CML-BP) 很少会出现早期T细胞前体急性淋巴细胞白血病 (ETP-ALL). 这些侵袭性病例需要密集治疗,干细胞移植可能会改善结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性骨髓性白血病爆发期 (CML-BP) 通常涉及骨髓性或前体B免疫类型.
- 早期T细胞前体急性淋巴细胞白血病 (ETP-ALL) 是一种罕见的急性淋巴细胞白血病亚型.
- 带有ETP-ALL的CML-BP异常罕见,这给诊断和治疗带来了挑战.
研究的目的:
- 描述CML-BP和ETP-ALL患者的临床病理学,免疫类型和分子遗传特征.
- 为了审查有关这种罕见实体的文献.
- 评估治疗结果和潜在的治疗策略.
主要方法:
- 3名患有CML-BP和ETP-ALL的患者的病例系列.
- 针对BCR::ABL1重新排列的免疫类型和光在位杂交 (FISH) 测定.
- 下一代测序用于突变分析.
- 文献综述. 这是一个文献综述.
主要成果:
- 一名患者有慢性髓性白血病慢性阶段的病史;另外两名患者被直接诊断出.
- 在两个案例中,BCR::ABL1重新排列证实了CML-BP.
- 爆发对细胞质CD3,CD7,CD33,CD117和色CD5呈阳性,对CD1a和CD8呈阴性.
- 发现的突变包括TET2,BCOR,RUNX1和STAG2.
- 两名患者在诊断后大约40天内死亡,尽管接受了化疗和氨酸激酶抑制剂.
- 一名患者在干细胞移植后在诊断后的14个月内存活.
结论:
- CML-BP可以呈现为ETP-ALL,一种罕见但具有攻击性的临床实体.
- 强化治疗,包括化疗和氨酸激酶抑制剂,是适用的.
- 干细胞移植可能为特定患者提供生存益处.
相关概念视频
Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Disorders of Leukocytes
914
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
914


